Foradil in children with chronic lung diseases
Abstract
A course of inhaled therapy with Foradil 12 mcg twice a day for 2 weeks was performed in 12 children with chronic lung diseases manifesting by the bronchoobstructive syndrome. The children's age was 10 to 17 yrs. The clinical and functional efficacy of the drug in children with chronic lung diseases was shown. All the patients demonstrated positive clinical dynamics under the treatment, namely correction of the bronchoobstructive syndrome. The positive effect was noted for the first 2 days of the treatment but the defined solution of the obstructive signs was obtained for 2 to 4 days of the therapy in 9 patients and to 7-9-th day in 3 patients. The positive clinical change was accompanied by improvement in the lung function. Any adverse effects of the drug were not found.
About the Authors
I. K. Volkov
Научный центр здоровья детей РАМН
Russian Federation
Russian Federation
O. F. Lukina
Научный центр здоровья детей РАМН
Russian Federation
Russian Federation
I. D. Fisenko
Научный центр здоровья детей РАМН
Russian Federation
Russian Federation
References
1. Бринстер А.А. Роль бранхамеллы катаралис в этиологии хронических бронхолегочных заболеваний у детей. Автореф. дис. ... канд. мед. наук. М. 1994.
2. Геппе Н.А.,Карпушкина А.В. Направления совершенствования бронхолитической терапии при бронхиальной астме у детей и подростков. Consilium Medicum. 2001; 3 (14).
3. Геппе Н.А. Современные представления о тактике лечения бронхиальной астмы у детей. Рус. мед. журн. 2002; 10 (7): 353-358.
4. Княжеская Н.П. Форадил в терапии бронхиальной астмы и ХОБЛ. Атмосфера 2001; 1:26-28.
5. Лукина О.Ф. Функциональная диагностика бронхиальной обструкции у детей. Респир. забол. 2002; 4: 7-9.
6. Рачинский С.В., Таточенко В.К. (ред.) Болезни органов дыхания у детей: Руководство для врачей. М.: Медицина; 1987.
7. Рачинский С.В., Волков И.К., Симонова О.И. Принципы и стратегия терапии хронических воспалительных бронхолегочных заболеваний у детей. Дет. доктор 2001; 2: 63-66.
8. Таточенко В.К. (ред.) Практическая пульмонология детского возраста. М.; 2001.
9. Терапевтические подходы к лечению бронхообструктивного синдрома у детей с хроническими заболеваниями легких: Метод. рекомендации / Середа Е.В., Рачинский С.В., Волков И.К. и др. М.; 1999.
10. Becker A.B., Simons F.E.R., McMillan J.L., Faridy T. Formoterol, a new long acting selective ß2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma. J. Allergy Clin. Immunol. 1989; 84: 891-895.
11. Von Berg A., Berdel D. Formoterol and salbutamol metered aerosols: comparison of a new and an established ß2-agonist for their brochondilating efficacy in the treatment of childhood bronchial asthma. Pediatr. Pulmonol. 1989; 7: 89-93.
12. Bisgaard H. Delivery of inhaled medication to children. J. Asthma 1996; 34: 443-467.
13. Bisgaard H. Long-acting ß2-agonists in management of childhood asthma: a critical review of the literature. Pediatr. Pulmonol. 2000; 29: 221-234.
14. Daugbjerg P., Nielsen K.G., Skou M., Bisgaard И. Duration of action of formoterol and salbutamol dry-powder inhalation in prevention of exercise induced asthma in children. Acta Paediatr. 1996; 85: 684-687.
15. Foucard T., Lonnerholm G. A study with cumulative doses of formoterol and salbutamol in children with asthma. Eur. Respir. J. 1991; 4: 1147-1177.
16. Klug В., Bisgaard H. Specific airway resistance, interrupter resistance and respiratory impedance in healthy children aged 2-7 years. Pediatr. Pulmonol. 1998; 25: 322-331.
17. Nielsen K.G., Bisgaard H. Lung function response to cold air challenge in asthmatic and healthy children of 2 -5 years. Am. J. Respir. Crit. Care Med. 2000; 161: 1805-1809.
18. Nielsen K.G., Bisgaard H . Bronchodilatation and bronchoprotection in astmatic prescool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer. Ibid. 164 (2): 256-259.
19. Persistent asthma symptoms better controlled in kids taking foradil Aerolizer. New study shows. Press releases Novartis Pharmaceuticals USA, 5, 2001.
20. Stelmach I., Gorski P., Jerzynska J. et al. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children. Ann. Allergy Asthma Immunol. 2002; 89 (1): 67-73.
21. Wilton L.V., Shakir S.A. A post-marketing surveillance study of formoterol (Foradil): its usé in general practice in England. Drug Saf. 2002; 25 (3): 213-223.
Review
For citations:
Volkov I.K., Lukina O.F., Fisenko I.D. Foradil in children with chronic lung diseases. PULMONOLOGIYA. 2003;(2):93-96. (In Russ.)
Views:
168
Email this article 